Kidney Care Partners (KCP)—the nation’s leading kidney care multi-stakeholder coalition representing patient advocates, physician organizations, health professional groups, dialysis providers, ...

Omeros stock rises after a $340 million deal with Novo Nordisk. Learn about its improved risk profile and covered call trade ...

Recor Medical said today that it secured Medicare approval, granting coverage for the company's RADIANCE CED study.

Adverse changes in the heart’s structure and function are common in people with chronic kidney disease (CKD), warranting mitigating therapies.

Renal denervation (RDN) has increasingly gained attention in cardiovascular medicine as a potentially transformative approach ...

Rising chronic kidney disease prevalence and morbidity rates in 2023 make CKD the ninth leading cause of death globally, ...

SGLT2 inhibitors are a welcome addition to GN care, but the field is still grappling with the gap between molecular ...

Kidney Disease is a killer across Whanau Maori Kidney disease has a disproportionately large impact on Māori, leading to ...

Obesity severity is incrementally associated with a broad range of cardiometabolic and renal disease burden, as discovered by ...

Clinical pharmacist and investigator Catherine “Katie” Derington, PharmD, MS, led research that suggests liraglutide, semaglutide, and dulaglutide may be equally safe options for patients with type 2 ...

Obesity severity is incrementally associated with a broad range of cardiometabolic and renal disease burden, as discovered by ...

In a successful transplant in a man with brain death, scientists prevented the immune system from attacking a genetically ...